![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhM17SXvopLxwYzlO4YVxV8UFfVww00whk0Okzu4U1g0ORueFLwh1G6LwbHXKRXWCkluCJYd88gYd8ocyNwPad7-4nqCBvYSksPypPtCPKEp25yK7AawpDL2OiF2c4I11NywlmmeopE9vhQ/s200/faseb+jour.gif)
The FASEB Journal Published online before print August 26, 2009
Humans who carry a point mutation in the gene coding for alcohol dehydrogenase-1B (ADH1B*2; Arg47His) are markedly protected against alcoholism. Although this mutation results in a 100-fold increase in enzyme activity, it has not been reported to cause higher levels of acetaldehyde, a metabolite of ethanol known to deter alcohol intake. Hence, the mechanism by which this mutation confers protection against alcoholism is unknown.
To study this protective effect, the wild-type rat cDNA encoding rADH-47Arg was mutated to encode rADH-47His, mimicking the human mutation. The mutated cDNA was incorporated into an adenoviral vector and administered to genetically selected alcohol-preferring rats.
The Vmax of rADH-47His was 6-fold higher than that of the wild-type rADH-47Arg. Animals transduced with rAdh-47His showed a 90% increase in liver ADH activity and a 50% reduction in voluntary ethanol intake. In animals transduced with rAdh-47His, administration of ethanol (1g/kg) produced a short-lived increase of arterial blood acetaldehyde concentration to levels that were 3.5- to 5-fold greater than those in animals transduced with the wild-type rAdh-47Arg vector or with a noncoding vector
This brief increase (burst) in arterial acetaldehyde concentration after ethanol ingestion may constitute the mechanism by which humans carrying the ADH1B*2 allele are protected against alcoholism.
Read Full Abstract.
Request Reprint E-Mail: yisrael@uchile.cl
________________________________________________________________